[Clinical trial of a new molecule, sulpiride, in psychiatric practice].
D000275:Adjustment Disorders / Q000188:drug therapy; D000328:Adult; D000368:Aged; D001565:Benzoates / Q000009:adverse effects / Q000627:therapeutic use*; D003693:Delirium / Q000188:drug therapy; D004700:Endocrine System Diseases / Q000139:chemically induced; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders / Q000188:drug therapy*; D008875:Middle Aged; D009461:Neurologic Manifestations; D011618:Psychotic Disorders / Q000188:drug therapy; D011759:Pyrrolidines / Q000009:adverse effects / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D012877:Skin Manifestations; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use*
D001565:Benzoates; D011759:Pyrrolidines; D013449:Sulfonamides
Essai clinique d'une molécule nouvelle, le sulpiride, en pratique psychiatrique.